| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/30/2011 | US20110159607 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159599 Voltage Sensor Domains of Voltage-Dependent Ion Channel Proteins and Uses Thereof |
| 06/30/2011 | US20110159598 Crystal structure of the ccz-lz domain of nemo |
| 06/30/2011 | US20110159571 Adenovirus targeting |
| 06/30/2011 | US20110159541 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159526 Methods for prdicting pregnancy outcome in a subject by hcg assay |
| 06/30/2011 | US20110159514 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159488 Primers for Amplification and Sequencing of Eubacterial 16S rDNA for Identification |
| 06/30/2011 | US20110159486 Cell cycle switch 52(ccs52) and methods for increasing yield |
| 06/30/2011 | US20110159166 Novel canola protein isolate |
| 06/30/2011 | US20110159130 Reduction of endotoxin in polysialic acids |
| 06/30/2011 | US20110159112 Recombinant alpha-fetoprotein and compositions thereof |
| 06/30/2011 | US20110159043 Allogeneic vaccine and methods to synthesize same |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159039 Eliciting hcv-specific antibodies |
| 06/30/2011 | US20110159036 MVA expressing modified HIV envelope, GAG, and POL genes |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159028 Compositions and methods for diagnosing and treating urinary tract infections |
| 06/30/2011 | US20110159027 S. agalactiae antigens i & ii |
| 06/30/2011 | US20110159024 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 06/30/2011 | US20110159022 Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine |
| 06/30/2011 | US20110159018 Complement factor h-derived short consensus repeat-antibody constructs |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110158998 Helminth antigen and immunotherapy |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158952 Compositions and methods for treating human papillomavirus-mediated disease |
| 06/30/2011 | US20110158943 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 06/30/2011 | US20110158941 Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/30/2011 | US20110158938 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonists / antagonists activity |
| 06/30/2011 | US20110158936 Use of interleukin 17e for the treatment of cancer |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | US20110155605 Apo-2 ligand |
| 06/30/2011 | CA2785585A1 Vaccine compositions |
| 06/30/2011 | CA2785139A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | CA2784944A1 Synergic action of a prolyl protease and tripeptidyl proteases |
| 06/30/2011 | CA2782796A1 Compositions and methods for the treatment of angiogenesis-related eye diseases |
| 06/30/2011 | CA2782300A1 Gene dro1 controlling deep-rooted characteristics of plant and utilization of same |
| 06/29/2011 | EP2339348A2 Method for diagnosing neuro-degenerative disease |
| 06/29/2011 | EP2339347A1 Method of identifying transmembrane protein-interacting compounds |
| 06/29/2011 | EP2339344A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/29/2011 | EP2339339A1 Filler for affinity chromatography |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339034A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/29/2011 | EP2339033A1 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 06/29/2011 | EP2339029A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 06/29/2011 | EP2339028A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 06/29/2011 | EP2339017A2 Enhanced protein expression in bacillus |
| 06/29/2011 | EP2339016A2 Enhanced protein expression in bacillus |
| 06/29/2011 | EP2339015A1 Methods for altering protein production rates |
| 06/29/2011 | EP2339011A1 West Nile virus and Dengue 4 virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 06/29/2011 | EP2339006A2 DNA constructs for expression of heterologous polypeptides in plants |
| 06/29/2011 | EP2339005A2 DNA constructs for expression of heterologous polypeptides in plants |
| 06/29/2011 | EP2339004A1 Optimizing glycan processing in plants |
| 06/29/2011 | EP2339003A2 APO-2 ligand substitutional variants |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2338978A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/29/2011 | EP2338913A1 Chromosome 13-linked breast cancer susceptibility gene |
| 06/29/2011 | EP2338912A2 Recombinant triplex scaffold-base polypeptides |
| 06/29/2011 | EP2338911A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 06/29/2011 | EP2338910A1 Cytokine receptor Zcytor17 multimers |
| 06/29/2011 | EP2338909A1 Modified peptide of human acidic fibroblast growth factor |
| 06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
| 06/29/2011 | EP2338907A1 Novel immunogenic epitopes for immunotherapy |
| 06/29/2011 | EP2338906A1 Compostion and methods for increasing bone mineralization |
| 06/29/2011 | EP2338905A2 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 06/29/2011 | EP2338904A1 Nisin derivatives and the use thereof |
| 06/29/2011 | EP2338903A1 A canine vaccine for protection against ehrlichiosis |
| 06/29/2011 | EP2338902A1 Klebsiella antigens |
| 06/29/2011 | EP2338901A1 Replikin peptides and uses thereof |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338897A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 06/29/2011 | EP2338894A1 Flavivirus fusion inhibitors |
| 06/29/2011 | EP2338513A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/29/2011 | EP2338510A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 06/29/2011 | EP2338505A2 Vault and vault-like carrier molecules |
| 06/29/2011 | EP2338504A2 Vault and vault-like carrier molecules |
| 06/29/2011 | EP2338333A2 Glycopegylation methods and proteins/peptides produced by the methods |
| 06/29/2011 | EP2338056A2 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 06/29/2011 | EP2337868A1 Detection of granulosa-cell tumors |
| 06/29/2011 | EP2337854A2 New tomato ethylene response factors and uses thereof |
| 06/29/2011 | EP2337853A1 Plants with increased yield (lt) |
| 06/29/2011 | EP2337798A1 Bsa-specific antibodies |
| 06/29/2011 | EP2337797A2 Method for producing double-crosslinked collagen |
| 06/29/2011 | EP2337796A1 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation |
| 06/29/2011 | EP2337795A2 Mhc multimers in cancer vaccines and immune monitoring |
| 06/29/2011 | EP2337794A2 An improved process for pegylation of proteins |
| 06/29/2011 | EP2337793A1 Methods of making concentrated fibrinogen- and platelet containing compositions |
| 06/29/2011 | EP2337792A1 Polypeptides having antimicrobial activity |
| 06/29/2011 | EP2337791A1 Utilization of fatty acid desaturases from hemiselmis spp |
| 06/29/2011 | EP2337790A1 Clostridial neurotoxins with altered persistency |
| 06/29/2011 | EP2337788A1 Method of making biologically active alpha-beta peptides |
| 06/29/2011 | EP2337585A1 Polymer conjugates of glp-2-like peptides |
| 06/29/2011 | EP2337582A1 Bovine herpes virus -1 compositions, vaccines and methods |
| 06/29/2011 | EP1970382B1 Activated collagen scaffold materials and their special fused active restoration factors |
| 06/29/2011 | EP1861419B1 Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| 06/29/2011 | EP1781690B1 Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics |